ST Humanwell (600079.SH): Lubiprostone Soft Capsules Obtain U.S. FDA Approval Number

Zhitong Finance APP News, ST Renfu (600079.SH) announced that its wholly-owned subsidiary Renfu Pukang Pharmaceutical (Wuhan) Co., Ltd. (referred to as "Renfu Pukang") recently received approval from the U.S. Food and Drug Administration (FDA) for lubiprostone soft capsules.